Cargando…

Tissue Factor–Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes

Tissue factor (TF) is an integral membrane protein widely expressed in normal human cells. Blood coagulation factor VII (fVII) is a key enzyme in the extrinsic coagulation cascade that is predominantly secreted by hepatocytes and released into the bloodstream. The TF–fVII complex is aberrantly expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koizume, Shiro, Miyagi, Yohei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562604/ https://www.ncbi.nlm.nih.gov/pubmed/26396550 http://dx.doi.org/10.4137/BIC.S29318

Ejemplares similares

Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O(2) and Plasma Supply
por: Koizume, Shiro, et al.
Publicado: (2017)

Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells
por: Yokota, N, et al.
Publicado: (2009)

Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications
por: Koizume, Shiro, et al.
Publicado: (2022)

Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia
por: Koizume, Shiro, et al.
Publicado: (2016)

Diverse Mechanisms of Sp1-Dependent Transcriptional Regulation Potentially Involved in the Adaptive Response of Cancer Cells to Oxygen-Deficient Conditions
por: Koizume, Shiro, et al.
Publicado: (2015)

Authors' reply to the Letter to the Editor: Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer
por: Koizume, Shiro, et al.
Publicado: (2022)

Tissue factor pathway inhibitor-2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix
por: Ota, Yukihide, et al.
Publicado: (2021)

Anti-apoptotic genes are synergistically activated in OVSAYO cells cultured under conditions of serum starvation and hypoxia
por: Koizume, Shiro, et al.
Publicado: (2015)

Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer
por: Kobayashi, Satoshi, et al.
Publicado: (2021)

Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer
por: Koizume, Shiro, et al.
Publicado: (2015)

HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic conditions in ovarian cancer cells
por: Koizume, Shiro, et al.
Publicado: (2012)

Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy
por: Napolitano, Mariasanta, et al.
Publicado: (2017)

Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency
por: Seanoon, Karnsasin, et al.
Publicado: (2022)

Annexin A4 Is Involved in Proliferation, Chemo-Resistance and Migration and Invasion in Ovarian Clear Cell Adenocarcinoma Cells
por: Mogami, Tae, et al.
Publicado: (2013)

Cancer cell‐derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression through fibronectin
por: Koizume, Shiro, et al.
Publicado: (2023)

Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
por: Rajpurkar, Madhvi, et al.
Publicado: (2018)

Congenital factor VII deficiency: Multidisciplinary approach is the key to successful perioperative outcome
por: Tandale, Sushama Raghunath, et al.
Publicado: (2017)

Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII
por: Hu, Yong, et al.
Publicado: (2022)

Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy
por: Hu, Zhiwei, et al.
Publicado: (2016)

Novel factor VII gene mutations in six families with hereditary coagulation factor VII deficiency
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
por: Francis, J. L., et al.
Publicado: (1992)

MicroRNAs as Key Regulators of Ovarian Cancers
por: Satapathy, Sandeep, et al.
Publicado: (2019)

Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
por: Arakawa, Noriaki, et al.
Publicado: (2016)

Overview of the human pharmacokinetics of recombinant activated factor VII
por: Klitgaard, Thomas, et al.
Publicado: (2008)

Recombinant activated factor VII in post partum haemorrhage
por: Magon, Navneet, et al.
Publicado: (2013)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

MPS VII – Extending the classical phenotype
por: Oldham, A., et al.
Publicado: (2022)

Acquired deficiency of coagulation factor VII
por: da Silva, Vanessa Afonso, et al.
Publicado: (2015)

Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer
por: Kroone, Chantal, et al.
Publicado: (2023)

Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma
por: Pusateri, Anthony E, et al.
Publicado: (2005)

Genotype and phenotype correlation in intracranial hemorrhage in neonatal factor VII deficiency among Thai children
por: Traivaree, Chanchai, et al.
Publicado: (2017)

Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
por: Klymenko, Yuliya, et al.
Publicado: (2017)

Meta-Analysis of Factor V, Factor VII, Factor XII, and Factor XIII-A Gene Polymorphisms and Ischemic Stroke
por: Keat Wei, Loo, et al.
Publicado: (2019)

Factor VII Gene Defects: Review of Functional Studies and Their Clinical Implications
por: Shahbazi, Shirin, et al.
Publicado: (2019)

Anticoagulation Therapy Considerations in Factor VII Deficiency
por: Paulus, Eric, et al.
Publicado: (2016)

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
por: Johansson, Pär I, et al.
Publicado: (2010)

Phenotypic flexibility as key factor in the human nutrition and health relationship
por: van Ommen, Ben, et al.
Publicado: (2014)

Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report
por: Dąbrowski, Filip A., et al.
Publicado: (2021)

Finite Volumes for Complex Applications VII
por: Fuhrmann, Jürgen, et al.
Publicado: (2014)

A candidate activation pathway for coagulation factor VII
por: Misenheimer, Tina M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lnf6obe7rldck6qiidoe5adovp